Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy

Ivana Sullivan, Juliana Salazar, Margarita Majem, Cinta Pallarés, Elisabeth del Río, David Páez, Montserrat Baiget, Agustí Barnadas

Research output: Contribution to journalArticleResearchpeer-review

63 Citations (Scopus)

Abstract

© 2014 Elsevier Ireland Ltd. Genetic variants in DNA repair genes may play a role in the effectiveness of platinum-based chemotherapy in non-small cell lung cancer (NSCLC). We analyzed 17 SNPs in eight genes (. ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, XPA, XRCC1 and XRCC2) involved in DNA repair mechanisms and its association with outcome in NSCLC. This prospective study included patients with stages III and IV treated with platinum-based chemotherapy. All patients (n = 161) received cisplatin or carboplatin plus a third-generation drug. Additionally, stage IIIA and IIIB patients (n = 74) received concomitant or sequential radiotherapy. Germline polymorphisms were analyzed using the BioMark system in blood DNA samples. We found that in stage III patients, response was significantly associated with SNPs in ERCC1 and in ERCC3 genes, while radiotherapy-derived toxicity correlated with SNPs in the ERCC2 gene. In stage IV patients, response was associated with a genetic variant in the ERCC4 gene and survival with a SNP in the XRCC1 gene. The complexity of the DNA repair mechanisms along with the heterogeneity in the treatment of lung cancer could explain the role of multiple genes as putative biomarkers of patient outcome.
Original languageEnglish
Pages (from-to)160-166
JournalCancer Letters
Volume353
Issue number2
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • DNA repair
  • Non-small cell lung cancer
  • Platinum-based chemotherapy
  • Radiotherapy
  • Single nucleotide polymorphisms

Fingerprint Dive into the research topics of 'Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy'. Together they form a unique fingerprint.

Cite this